NASDAQ:CATB
Delisted

Catabasis Pharmaceuticals Stock Predictions

etoro logo Buy CATB
*Your capital is at risk
$3.36
+0.195 (+6.16%)
At Close: May 27, 2022
Currently predicting for Mon, 8 Jun 2026

CATB Prediction Chart

CATB Predictions History

Latest community submissions for CATB.
Predictor Target Session Target Price Result Direction Accuracy Score
Jul 18, 2017 $1.34 +8.06% $1.24 X 91.90% 0
Apr 18, 2017 $1.42 -12.35% $1.62 X 87.70% 0
JS JS Pro
Apr 10, 2017 $1.48 +3.50% $1.43 X 96.50% 0
Apr 10, 2017 $1.37 -4.20% $1.43 X 95.80% 0
Apr 5, 2017 $1.36 -2.16% $1.39 X 97.80% 0
JS JS Pro
Apr 3, 2017 $1.64 +7.19% $1.53 X 92.80% 0
JS JS Pro
Mar 27, 2017 $1.55 -0.64% $1.56 X 99.40% 3
Mar 27, 2017 $1.62 +3.85% $1.56 X 96.20% 0
Mar 20, 2017 $3.55 +144.83% Unrealistic Excluded from avg $1.45 X 0.00% 0
JS JS Pro
Mar 20, 2017 $1.47 +1.38% $1.45 X 98.60% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CATB with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CATABASIS PHARMACEUTICALS
Catabasis Pharmaceuticals
Catabasis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics to treat inflammatory and metabolic diseases. Its product pipeline includes CAT-1004, an oral small molecule that has completed Phase 1 clinical trials for the treatment of duchenne muscular dystrophy (DMD); CAT-2054, which is in Phase I clinical trial for the treatment of hypercholesterolemia i...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
4.09% May 06
GLBE
$31.61
1.65% May 05
SAP
$172.39
7.18% May 05
FIZZ
$34.11
7.04% May 01
ADBE
$243.57
3.23% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE